Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric Acute Myeloid Leukemia

NCT00887042 is registered in ClinicalTrials.gov with The Korean Society of Pediatric Hematology Oncology as lead sponsor.

NCT NCT00887042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00887042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric Acute Myeloid Leukemia
Lead sponsor
The Korean Society of Pediatric Hematology Oncology
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 30, 2006
Completion date
May 31, 2012
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia